The update reflects long-term clinical trial data showing that many patients with mCSCC or laCSCC experienced lasting responses
Pfizer and Valneva have been collaborating on VLA15’s development and commercialization since April 2020
Valneva will consolidate its French operations at its Lyon site and close its Nantes location
The deal, backed by Gavi and executed by UNICEF, could generate up to US$90 million in savings—enough to provide more than 30 million additional doses
The trials, designed to assess whether semaglutide could slow cognitive decline, showed no significant difference compared to placebo in the progression of Alzheimer’s disease over two years
The deliveries bring the innovative medicine to communities heavily impacted by HIV just five months after U.S. FDA approval
The new Bioprocess Design Center will serve as a cutting-edge scale-up hub for biologics and vaccine manufacturing
Solventum aims to accelerate innovation in acute wound care, expand its market reach, and deliver enhanced solutions for patients, clinicians, and shareholders
The collaboration aims to make Alzheimer’s biomarker testing more accessible and less intimidating
Subscribe To Our Newsletter & Stay Updated